Successful treatment of adult IgA nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine.

Case reports in nephrology and urology Pub Date : 2012-01-01 Epub Date: 2012-06-05 DOI:10.1159/000339401
Hideo Okonogi, Tetsuya Kawamura, Nanae Matsuo, Yasuto Takahashi, Izumi Yamamoto, Hiraku Yoshida, Kentaro Koike, Takashi Yokoo, Kensuke Joh, Yasunori Utsunomiya, Kazushige Hanaoka, Tatsuo Hosoya
{"title":"Successful treatment of adult IgA nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine.","authors":"Hideo Okonogi,&nbsp;Tetsuya Kawamura,&nbsp;Nanae Matsuo,&nbsp;Yasuto Takahashi,&nbsp;Izumi Yamamoto,&nbsp;Hiraku Yoshida,&nbsp;Kentaro Koike,&nbsp;Takashi Yokoo,&nbsp;Kensuke Joh,&nbsp;Yasunori Utsunomiya,&nbsp;Kazushige Hanaoka,&nbsp;Tatsuo Hosoya","doi":"10.1159/000339401","DOIUrl":null,"url":null,"abstract":"<p><p>A 41-year-old male patient was admitted to our hospital due to massive proteinuria and hematuria. His 24-hour urinary protein excretion and the number of urinary erythrocytes were 3.91 g/day and 50-99/high-power field, respectively. A renal biopsy showed a severe pathological pattern of immunoglobulin A nephropathy (IgAN) that involved marked endocapillary proliferation and segmental sclerosis (Oxford-MEST score: M0, E1, S1, T0). Because he had nephrotic-level proteinuria with severe pathological findings, which are tonsillectomy and corticosteroid pulse therapy-resistant characteristics, he received mizoribine for a long period as part of the combination therapy using corticosteroid, tonsillectomy, dipyridamole, warfarin and renin-angiotensin-aldosterone system blockers. Twelve months after the beginning of treatment, his urinary findings were normal. In this report, we describe the pathological findings and successful treatment course, and discuss the potential effects of long-term coadministration of mizoribine for adult IgAN treatment.</p>","PeriodicalId":89663,"journal":{"name":"Case reports in nephrology and urology","volume":"2 1","pages":"53-8"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000339401","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case reports in nephrology and urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000339401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/6/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

A 41-year-old male patient was admitted to our hospital due to massive proteinuria and hematuria. His 24-hour urinary protein excretion and the number of urinary erythrocytes were 3.91 g/day and 50-99/high-power field, respectively. A renal biopsy showed a severe pathological pattern of immunoglobulin A nephropathy (IgAN) that involved marked endocapillary proliferation and segmental sclerosis (Oxford-MEST score: M0, E1, S1, T0). Because he had nephrotic-level proteinuria with severe pathological findings, which are tonsillectomy and corticosteroid pulse therapy-resistant characteristics, he received mizoribine for a long period as part of the combination therapy using corticosteroid, tonsillectomy, dipyridamole, warfarin and renin-angiotensin-aldosterone system blockers. Twelve months after the beginning of treatment, his urinary findings were normal. In this report, we describe the pathological findings and successful treatment course, and discuss the potential effects of long-term coadministration of mizoribine for adult IgAN treatment.

Abstract Image

Abstract Image

联合治疗成人IgA肾病伴肾水平蛋白尿的成功治疗,包括长期联合使用米佐瑞滨。
患者男,41岁,因大量蛋白尿、血尿入住我院。24小时尿蛋白排泄量3.91 g/d,尿红细胞数50-99个/高倍视野。肾活检显示严重的免疫球蛋白A肾病(IgAN)病理模式,包括明显的毛细血管内增生和节段性硬化(Oxford-MEST评分:M0, E1, S1, T0)。由于他患有肾水平蛋白尿,病理表现为扁桃体切除术和皮质类固醇脉冲治疗抵抗,他长期接受米佐利滨作为皮质类固醇、扁桃体切除术、双嘧达莫、华法林和肾素-血管紧张素-醛固酮系统阻滞剂联合治疗的一部分。开始治疗12个月后,他的尿液检查结果正常。在本报告中,我们描述了病理结果和成功的治疗过程,并讨论了长期联合米佐瑞滨治疗成人IgAN的潜在影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信